//
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial
Cholesterol-Lowering Agents
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association
Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients
Association Between Living in Food Deserts and Cardiovascular Risk
Translational Perspective on Epigenetics in Cardiovascular Disease
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial
Obesity, Diabetes, and Acute Coronary Syndrome: Differences Between Asians and Whites